Lord, Abbett & Co
ASND icon

Lord, Abbett & Co’s Ascendis Pharma A/S ASND Stock Holding History

Lord, Abbett & Co’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.7M Sell
77,558
-66,910
-46% -$16.9M 0.05% 316
2026
Q2 		$38.5M Sell
144,468
-849
-0.6% -$198K 0.11% 214
2026
Q1 		$33.2M Buy
145,317
+25,120
+21% +$5.63M 0.11% 207
2025
Q4 		$25.6M Sell
120,197
-31,230
-21% -$6.45M 0.08% 245
2025
Q3 		$30.1M Sell
151,427
-2,749
-2% -$513K 0.09% 235
2025
Q2 		$26.6M Buy
+154,176
New +$25.1M 0.09% 242
2018
Q3 		– Sell
-146,403
Closed -$9.7M – 826
2018
Q2 		$9.7M Sell
146,403
-58,304
-28% -$3.83M 0.03% 630
2018
Q1 		$13.4M Sell
204,707
-47,991
-19% -$2.7M 0.04% 570
2017
Q4 		$10.1M Sell
252,698
-5,955
-2% -$217K 0.03% 620
2017
Q3 		$9.38M Buy
+258,653
New +$7.42M 0.03% 649

Other funds holding ASND

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Lord, Abbett & Co's ASND Position: Q3 2026 in Review

Lord, Abbett & Co reduced its Ascendis Pharma A/S (ASND) stake by 46% in Q3 2026, selling an estimated $16.9M and leaving 77,558 shares worth $17.7M. The position accounts for 0.05% of the portfolio, ranked #316.

Lord, Abbett & Co first reported a position in ASND in Q3 2017 and has held it in 10 quarters since. The position peaked at $38.5M in Q2 2026. 238 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Lord, Abbett & Co held 77,558 shares of Ascendis Pharma A/S worth $17.7M as of Q3 2026.
  • Lord, Abbett & Co sold 66,910 Ascendis Pharma A/S shares in Q3 2026, an estimated $16.9M.
  • Ascendis Pharma A/S made up 0.05% of Lord, Abbett & Co's portfolio in Q3 2026, its #316 holding.
  • Lord, Abbett & Co first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 10 quarters since.
  • Lord, Abbett & Co's Ascendis Pharma A/S position peaked at $38.5M in Q2 2026.
  • 238 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.